ANIK FY 2013 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ANIKAnika Therapeutics, Inc.

$207M

FY 2013 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$75M+5.2% YoY

Gross Profit

$52M69.7% margin

Operating Income

$33M43.4% margin

Net Income

$21M27.4% margin

EPS (Diluted)

$1.39

Cash Flow

Operating Cash Flow

$25M

Free Cash Flow

$25M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$156M

Total Liabilities

$20M

Stockholders' Equity

$136M

Cash & Equivalents

$63M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$75M	$71M	+5.2%
Gross Profit	$52M	$42M	+23.5%
Operating Income	$33M	$20M	+65.4%
Net Income	$21M	$12M	+75.0%